HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jorge Soliz Selected Research

Respiratory System Agents (Respiratory Stimulants)

10/2019Erythropoietin and caffeine exert similar protective impact against neonatal intermittent hypoxia: Apnea of prematurity and sex dimorphism.
11/2015The central chemosensitivity is not altered by cerebral erythropoietin.
6/2015Endogenous brain erythropoietin is a potent sex-specific respiratory stimulant in adult and newborn mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jorge Soliz Research Topics

Disease

26Hypoxia (Hypoxemia)
01/2022 - 03/2002
4COVID-19
01/2022 - 01/2020
3Respiratory Insufficiency (Respiratory Failure)
01/2022 - 08/2014
3Apnea
01/2021 - 01/2013
3Hyperoxia
06/2009 - 10/2007
2Wounds and Injuries (Trauma)
10/2021 - 11/2017
2Stroke (Strokes)
01/2018 - 02/2005
2Ischemia
12/2005 - 02/2005
1Critical Illness (Critically Ill)
01/2022
1Sleep Apnea Syndromes (Sleep Apnea)
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Brain Injuries (Brain Injury)
01/2021
1Hypercapnia
01/2021
1Asthma (Bronchial Asthma)
01/2020
1Altitude Sickness (Mountain Sickness)
01/2020
1Hypertension (High Blood Pressure)
01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2019
1Chronic Renal Insufficiency
01/2018
1Sleep Wake Disorders
01/2018
1Anemia
08/2015
1Autistic Disorder (Autism)
11/2013
1Rett Syndrome (Rett's Disorder)
11/2013
1Chronic Disease (Chronic Diseases)
08/2012
1Inflammation (Inflammations)
05/2010
1Brain Hypoxia (Cerebral Hypoxia)
12/2005
1Brain Ischemia (Cerebral Ischemia)
12/2005
1Ischemic Stroke
02/2005

Drug/Important Bio-Agent (IBA)

17ErythropoietinFDA Link
10/2021 - 02/2005
8Oxygen (Dioxygen)IBA
01/2022 - 08/2007
3Pharmaceutical PreparationsIBA
01/2022 - 08/2008
3Respiratory System Agents (Respiratory Stimulants)IBA
10/2019 - 06/2015
3Domperidone (Domperidon)IBA
06/2009 - 03/2002
2Estradiol (Delestrogen)FDA LinkGeneric
01/2019 - 12/2010
2Proteins (Proteins, Gene)FDA Link
01/2018 - 12/2016
1Urethane (Ethyl Carbamate)IBA
01/2021
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2021
1P-2 (P 2)IBA
01/2021
1Testosterone PropionateFDA Link
01/2021
1Testosterone (Sustanon)FDA Link
01/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021
1SphingosineIBA
01/2020
1Angiotensin-Converting Enzyme 2IBA
01/2020
1Caffeine (No Doz)FDA LinkGeneric
10/2019
1Hormones (Hormone)IBA
01/2019
1EnzymesIBA
01/2018
1Glutathione PeroxidaseIBA
01/2018
1NADP (NADPH)IBA
01/2018
1Oxidoreductases (Dehydrogenase)IBA
01/2018
1Superoxide DismutaseIBA
01/2018
1Oxidants (Oxidizing Agents)IBA
01/2018
1XanthineIBA
01/2018
1ProgesteroneFDA LinkGeneric
11/2017
1CytokinesIBA
11/2017
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
12/2016
1Transcription Factors (Transcription Factor)IBA
12/2016
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
12/2016
1Angiopoietin-2IBA
12/2016
1SteroidsIBA
06/2015
1Phosphotransferases (Kinase)IBA
01/2015
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2015
1U 0126 (UO 126)IBA
01/2015
1Protein Kinases (Protein Kinase)IBA
01/2015
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2015
1Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2013
18-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA
01/2013
1tetralinIBA
01/2013
1Serotonin (5 Hydroxytryptamine)IBA
01/2013
1oxidized low density lipoproteinIBA
05/2010
1Therapeutic UsesIBA
10/2009
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2007
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
08/2007

Therapy/Procedure

1Artificial Respiration (Mechanical Ventilation)
01/2022
1Therapeutics
01/2022
1Mechanical Ventilators (Ventilator)
01/2020
1Axotomy
02/2005